The contribution of lipids to coronary heart disease in diabetes mellitus.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of internal medicine. Supplement

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 7986307
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoprotein(a) and Diabetes: An update

  1993cited by this paper
• Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.

  1993cited by this paper
• Effects of self monitoring of triglyceride concentrations in non-insulin dependent diabetes.

  1993cited by this paper
• Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease.

  1992cited by this paper
• Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes.

  1992cited by this paper
• Relation of Lipid Peroxides to Macrovascular Disease in Type 2 Diabetes

  1991cited by this paper
• Alterations in very low density lipoprotein subfractions in normotriglyceridemic non-insulin-dependent diabetics.

  1991cited by this paper
• Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment.

  1991cited by this paper
• Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus.

  1991cited by this paper
• Role of Oxidative Stress in Development of Complications in Diabetes

  1991cited by this paper
• Postprandial lipemia, fenofibrate and coronary artery disease.

  1990cited by this paper
• Influence of Obesity, Impaired Glucose Tolerance, and NIDDM on LDL Structure and Composition: Possible Link Between Hyperinsulinemia and Atherosclerosis

  1990cited by this paper
• Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.

  1990cited by this paper
• Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B.

  1990cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes.

  1989cited by this paper
• Apolipoprotein E polymorphism and lipoproteins in insulin-treated diabetes mellitus.

  1989cited by this paper
• Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes

  1989cited by this paper
• Increased Superoxide Production by Mononuclear Cells of Patients With Hypertriglyceridemia and Diabetes

  1988cited by this paper
• Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis.

  1988cited by this paper
• Glycosylation of Low-Density Lipoprotein Enhances Cholesteryl Ester Synthesis in Human Monocyte-Derived Macrophages

  1988cited by this paper
• Banting lecture 1988. Role of insulin resistance in human disease.

  1988cited by this paper
• Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients

  1988cited by this paper
• Lipoprotein metabolism in diabetes mellitus.

  1987cited by this paper
• The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.

  1987cited by this paper
• Relationships Between Plasma Lipoprotein Concentrations and Insulin Action in an Obese Hyperinsulinemic Population

  1987cited by this paper
• Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics.

  1987cited by this paper
• Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus

  1987cited by this paper
• Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

  1986cited by this paper
• The bidirectional flux of cholesterol between cells and lipoproteins. Effects of phospholipid depletion of high density lipoprotein.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for myocardial infarction.

  1986cited by this paper
• Metabolism of Low-Density Lipoprotein from Patients with Diabetic Hypertriglyceridemia by Cultured Human Skin Fibroblasts

  1985cited by this paper
• Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology.

  1985cited by this paper
• Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages.

  1985cited by this paper
• Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics.

  1985cited by this paper
• Retarded chylomicron apolipoprotein-B catabolism in Type 2 (non-insulin-dependent) diabetic subjects with lipaemia

  1984cited by this paper
• Glucosylation of Low-Density Lipoproteins to an Extent Comparable to That Seen in Diabetes Slows Their Catabolism

  1984cited by this paper
• Clustering of heart disease risk factors in diabetic compared to nondiabetic adults.

  1983cited by this paper
• Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.

  1983cited by this paper
• The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study

  1983cited by this paper
• Abnormal Composition of High Density Lipoproteins in Non-insulin-dependent Diabetics

  1982cited by this paper
• Plasma lipids and diabetes mellitus in an adult community.

  1982cited by this paper
• Lipoprotein‐Cholesterol Distributions in Selected North American Populations: The Lipid Research Clinics Program Prevalence Study

  1980cited by this paper
• Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

  1979cited by this paper
• Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.

  1978cited by this paper
• Serum high density lipoprotein in diabetic patients

  1977cited by this paper
• Hyperlipemia and Diabetes Mellitus

  1966cited by this paper

• Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle

  2021cites this paper
• Sleep duration and smoking are associated with coronary heart disease among US adults with type 2 diabetes: Gender differences.

  2017cites this paper
• FoxO1: A Conductor of Insulin Signaling to Glucose and Lipid Metabolism

  2016cites this paper
• Hypertriglyceridemia on beta-cell function Effect of Hypertriglyceridemia on Beta-Cell Mass and Function in ApoC 3 Transgenic Mice

  2016cites this paper
• Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice*

  2016cites this paper
• FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver.

  2014cites this paper
• ATF4 Protein Deficiency Protects against High Fructose-induced Hypertriglyceridemia in Mice*

  2013cites this paper
• Vegetarian and vegan diets in type 2 diabetes management.

  2009cites this paper
• Evaluation of a type 1 diabetes serum cohort by SELDI‐TOF MS protein profiling

  2009cites this paper
• LIPID PEROXIDATION AND ANTIOXIDANT DEFENSE SYSTEMS IN TYPE II DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE

  2008cites this paper
• FoxO1 integrates insulin signaling to VLDL production

  2008cites this paper
• Cardiovascular Prevention in High-Risk Patients: Evaluating Current Evidence to Improve Outcomes in Managed Care

  2008cites this paper
• Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.

  2008cites this paper
• Low-density lipoprotein cholesterol in high-risk asymptomatic individuals.

  2007cites this paper
• The importance of obesity and hyperlipidaemia in patients with renal transplants

  2006cites this paper
• CARACTERIZAÇÃO DO PERFIL DE ÁCIDOS GRAXOS DO TIMO, BAÇO E LINFONODO MESENTÉRICO DE RATOS DIABETICOS E OS EFEITOS DA SUPLEMENTAÇÃO COM FOSFATIDILCOLINA SOBRE A COMPOSIÇÃO LIPÍDICA DAS MEMBRANAS E FUNCIONALIDADE DE CÉLULAS B e T.

  2006cites this paper
• STUDY OF SERUM LIPID AND LIPOPROTEIN LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE AND DIABETES MELLITUS

  2005cites this paper
• Clinical Use and Pathogenetic Basis of Laboratory Tests for the Evaluation of Primary Arterial Hypertension

  2005cites this paper
• Apolipoprotein CIII promotes Ca2+-dependent beta cell death in type 1 diabetes.

  2004cites this paper
• Clinical Trials and Lipid Guidelines for Type II Diabetes

  2004cites this paper
• Impact of age and duration on sight–threatening retinopathy in South Asians and Caucasians attending a diabetic clinic

  2004cites this paper
• Apolipoprotein CIII promotes Ca2+-dependent β cell death in type 1 diabetes

  2004cites this paper
• Niveles séricos de la Proteína Transportadora de Esteres de Colesterol (CETP) y perfil lipídico de pacientes diabéticos tipo 2. Unidad de diabetes, Ciudad Hospitalaria Dr. Enrique Tejera

  2003cites this paper
• Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study.

  2003cites this paper
• Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin.

  2001cites this paper
• Treating type 2 diabetes - today's targets, tomorrow's goals.

  2001cites this paper
• Treating type 2 diabetes – today's targets, tomorrow's goals

  2001cites this paper
• Physiologie effects of individual fatty acids in animal and human body, with particular attention to coronary heart disease risk modulation

  2001cites this paper
• High density lipoprotein cholesterol increases with living altitude.

  2000cites this paper
• Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients.

  1998cites this paper
• Dyslipidemia in Noninsulin-Dependent Diabetes Mellitus

  1997cites this paper
• Diabetes in British South Asians: Nature, Nurture, and Culture

  1997cites this paper
• Plasma albumin and platelet function: relevance to atherogenesis and thrombosis.

  1996cites this paper
• Mrs Sprat's Diabetes: Some Metabolic Insights

  1996cites this paper
• Potential role of lipids in the progression of diabetic nephropathy.

  1996cites this paper